Recombinant multi-species RNF185 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF185 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables ubiquitin binding activity; ubiquitin protein ligase activity; and ubiquitin-like protein conjugating enzyme binding activity. Involved in positive regulation of ERAD pathway; protein autoubiquitination; and ubiquitin-dependent ERAD pathway. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: E3 ubiquitin-protein ligase RNF185,RING finger protein 185,RNF185,Rnf185

Target products collectionGo to RNF185 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1520-Ag-1/ GM-Tg-hg-IP1520-Ag-2 Human RNF185 protein Human
GM-Tg-rg-IP1520-Ag-1/ GM-Tg-rg-IP1520-Ag-2 Rat RNF185 protein Rat
GM-Tg-mg-IP1520-Ag-1/ GM-Tg-mg-IP1520-Ag-2 Mouse RNF185 protein Mouse
GM-Tg-cynog-IP1520-Ag-1/ GM-Tg-cynog-IP1520-Ag-2 Cynomolgus/Rhesus macaque RNF185 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1520-Ag-1/ GM-Tg-felg-IP1520-Ag-2 Feline RNF185 protein Feline
GM-Tg-cang-IP1520-Ag-1/ GM-Tg-cang-IP1520-Ag-2 Canine RNF185 protein Canine
GM-Tg-bovg-IP1520-Ag-1/ GM-Tg-bovg-IP1520-Ag-2 Bovine RNF185 protein Bovine
GM-Tg-equg-IP1520-Ag-1/ GM-Tg-equg-IP1520-Ag-2 Equine RNF185 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1520-Ag-1/ GM-Tg-hg-IP1520-Ag-2; GM-Tg-rg-IP1520-Ag-1/ GM-Tg-rg-IP1520-Ag-2;
GM-Tg-mg-IP1520-Ag-1/ GM-Tg-mg-IP1520-Ag-2; GM-Tg-cynog-IP1520-Ag-1/ GM-Tg-cynog-IP1520-Ag-2;
GM-Tg-felg-IP1520-Ag-1/ GM-Tg-felg-IP1520-Ag-2; GM-Tg-cang-IP1520-Ag-1/ GM-Tg-cang-IP1520-Ag-2;
GM-Tg-bovg-IP1520-Ag-1/ GM-Tg-bovg-IP1520-Ag-2; GM-Tg-equg-IP1520-Ag-1/ GM-Tg-equg-IP1520-Ag-2
Products Name RNF185 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RNF185
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF185 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.